Gilead CEO Takes Aim at Medicare Pricing: 'Pill Penalty' Threatens Drug Innovation
Gilead stock rose after Q3 earnings beat Wall Street estimates and strong HIV drug demand prompted an increased 2026 sales forecast.
Stocks · News reference
RBC Capital Markets Raises Price Target on Gilead Sciences
RBC Capital Markets increased its price target for Gilead Sciences to $131 from $126 while maintaining a 'Sector Perform' rating.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Incyte To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday
Analysts raised targets for Cheniere and Incyte, while cutting Stryker, Roblox, Intel and Honeywell; Bright Horizons was downgraded.
Cantor Fitzgerald and Needham Update Gilead Sciences Ratings
Analysts at Cantor Fitzgerald and Needham maintained positive ratings on Gilead Sciences following the company's third-quarter earnings report.
Gilead Sciences and Assembly Biosciences Update Collaboration on ABI-6250
Gilead Sciences maintains an option to license Assembly Biosciences' ABI-6250 for chronic HDV infection following the completion of a Phase 2 clinical study.
Gilead Sciences Announces Third Quarter 2026 Financial Results
Gilead Sciences reported strong third-quarter 2026 financial results, exceeding analyst expectations for both revenue and earnings per share, and raised its full-year base business revenue guidance.
Breakfast News: Brace for an AI Optics Shake-up
Marvell is reportedly in advanced talks to acquire Lumentum to control AI optics supply, a critical bottleneck in AI infrastructure. Alphabet slumped 10% despite strong cloud growth due to massive capital expenditures and negative free cash flow. Several earnings reports showed mixed results: Fortinet fell 25% on weak guidance, ServiceNow dropped 19% due to AI deployment costs, while Microsoft, Sterling Infrastructure, and Chipotle posted gains. DoorDash may acquire Instacart to compete in grocery delivery dominated by Instacart's 68% market share.